ATE509097T1 - Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna - Google Patents

Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna

Info

Publication number
ATE509097T1
ATE509097T1 AT02799195T AT02799195T ATE509097T1 AT E509097 T1 ATE509097 T1 AT E509097T1 AT 02799195 T AT02799195 T AT 02799195T AT 02799195 T AT02799195 T AT 02799195T AT E509097 T1 ATE509097 T1 AT E509097T1
Authority
AT
Austria
Prior art keywords
hpivi
recombinant human
piv
cdna
recombinant
Prior art date
Application number
AT02799195T
Other languages
English (en)
Inventor
Brian Murphy
Peter Collins
Mario Skiadopoulos
Jason Newman
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE509097T1 publication Critical patent/ATE509097T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18641—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18661—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02799195T 2001-11-21 2002-11-21 Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna ATE509097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33196101P 2001-11-21 2001-11-21
PCT/US2002/037688 WO2003043587A2 (en) 2001-11-21 2002-11-21 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna

Publications (1)

Publication Number Publication Date
ATE509097T1 true ATE509097T1 (de) 2011-05-15

Family

ID=23296092

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02799195T ATE509097T1 (de) 2001-11-21 2002-11-21 Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna

Country Status (6)

Country Link
US (1) US7704509B2 (de)
EP (2) EP1456398B1 (de)
AT (1) ATE509097T1 (de)
AU (2) AU2002364121C1 (de)
CA (1) CA2467958A1 (de)
WO (1) WO2003043587A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287540A1 (en) * 1995-09-27 2005-12-29 Murphy Brian R Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
SG149684A1 (en) 2001-01-19 2009-02-27 Vironovative Bv A virus causing respiratory tract illness in susceptible animals
US20030232061A1 (en) * 2001-10-18 2003-12-18 Fouchier Ronaldus Adrianus Maria Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
US8715922B2 (en) * 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
KR101076102B1 (ko) 2002-02-21 2011-10-21 비로노바티브 비.브이. 메타뉴모바이러스에서 유래한 이종성 항원을 포함하는재조합 파라인플루엔자 바이러스 발현 시스템 및 백신
AU2003270824B2 (en) 2002-09-18 2009-02-19 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
JP2006524511A (ja) * 2003-04-25 2006-11-02 メッドイミューン バクシーンズ,インコーポレイティド メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン
CA2523319A1 (en) 2003-04-25 2004-11-11 Medimmune Vaccines, Inc. Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
WO2006110214A2 (en) * 2005-04-08 2006-10-19 Medimmune, Inc. Antibodies against mammalian metapneumovirus
WO2008048269A2 (en) * 2005-10-20 2008-04-24 Combimatrix Corporation Microarray for pathogen identification
US20100330120A1 (en) * 2007-05-08 2010-12-30 Collins Peter L Human parainfluenza viruses having separated p and c genes
WO2009012155A2 (en) * 2007-07-13 2009-01-22 Medimmune, Llc Preparation of negative-stranded rna viruses by electroporation
GB0719818D0 (en) * 2007-10-11 2007-11-21 Asterion Ltd Growth hormone fusion polypeptides
US20090186050A1 (en) * 2007-11-16 2009-07-23 Fouchier Ron A M Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
EP2313428A2 (de) * 2008-07-01 2011-04-27 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Rekombinante human parainfluenza type 1-viren (hpiv1s), die mutationen im c-protein enthalten oder bei denen das c-protein deletiert ist, sind in westlichen grün meerkatzen und in mit cilien versehenen epithelzellen der menschlichen luftwege abgeschwächt und stellen potentielle impfstoffkandidaten für hpiv1 dar
LT2702159T (lt) * 2011-04-28 2019-01-10 St. Jude Children`S Research Hospital Modifikuoto sendai viruso vakcina ir iliustratyvus vektorius
ES3058017T3 (en) 2015-01-20 2026-03-06 Us Health Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/bpiv3 f protein and uses thereof
CN116121206B (zh) * 2022-10-13 2024-12-06 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) 一种ⅺ型新城疫病毒(f48e9)的重组拯救病毒制备方法、重组病毒及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US708395A (en) 1901-04-15 1902-09-02 Oscar Peterson Device for digging ditches.
US2177396A (en) 1936-04-18 1939-10-24 Borden Co Milk bottle
DE3224404A1 (de) 1982-06-30 1984-01-05 LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl Reibungskupplung sowie verfahren zu deren montage
US4614197A (en) 1984-10-15 1986-09-30 Deere & Company Chaff spreading arrangement for a combine
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4763497A (en) 1986-09-03 1988-08-16 Clover Co., Ltd. Lock device for double sliding doors
US5938597A (en) 1995-05-04 1999-08-17 Stratbucker; Robert A. Electrocardiograph bioelectric interface system and method of use
ATE181112T1 (de) 1995-08-09 1999-06-15 Schweiz Serum & Impfinst Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
US6699476B1 (en) 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
EP0912724B1 (de) 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
DE69842165D1 (de) * 1997-05-23 2011-04-21 Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
US6410023B1 (en) 1997-05-23 2002-06-25 United States Of America Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
KR100940776B1 (ko) 1999-07-09 2010-02-11 더 가버먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 리프리젠티드 바이 더 디파트먼트 오브 헬스 앤 휴먼 서비씨즈 약독화된 사람-소 키메라 파라인플루엔자바이러스(piv) 백신
JP4795597B2 (ja) 1999-12-10 2011-10-19 アメリカ合衆国 パラインフルエンザウィルス(piv)及びヒトの病原体により引き起こされる感染及び疾病を保護するためへの組換えpivのベクターとしての使用
US8379398B2 (en) 2011-03-23 2013-02-19 Phoenix Contact Development & Manufacturing, Inc. DIN rail mountable base for process fieldbus redundant power conditioner

Also Published As

Publication number Publication date
EP1456398B1 (de) 2011-05-11
WO2003043587A9 (en) 2011-06-09
WO2003043587A3 (en) 2004-04-22
US7704509B2 (en) 2010-04-27
CA2467958A1 (en) 2003-05-30
WO2003043587A2 (en) 2003-05-30
EP1456398A4 (de) 2006-09-27
AU2009202359A1 (en) 2009-07-02
US20040142448A1 (en) 2004-07-22
EP2100955A3 (de) 2009-12-02
EP2100955A2 (de) 2009-09-16
EP1456398A2 (de) 2004-09-15
AU2002364121C1 (en) 2010-02-18
AU2002364121B2 (en) 2009-03-12
AU2002364121A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
EP1456398A4 (de) Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
WO2004027037A3 (en) RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
WO2001042445A3 (en) USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
WO2005014626A3 (en) Recombinant human metapneumovirus and its use
ATE408693T1 (de) Attenuiertes human-bovines chimärisches parainfluenzavirus als impfstoff
BR0013195A (pt) Produção de vacinas de virus sincicial respiratório quimérico humano-bovino, atenuado
EP1326633A4 (de) Zusammensetzung mit immunogenen mikroteilchen
ATE442866T1 (de) Fusionsproteine aus mycobakterium tuberculosis
WO2003048184A3 (en) Flavivirus ns1 subunit vaccine
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
ATE417097T1 (de) Rekombinantes respiratorische synzytialvirus expressionssystem und impfstoffe
CY1109036T1 (el) Εμβολιο περιλαμβανον εναν εξασθενημενο ιο πανωλης
BR0312173A (pt) Mólecula de cdna, molécula e sequência de cdna recombinante, vetor, processo de preparação de partìculas de vìrus do sarampo infeccioso, composição imunogênica, composição de vacina e vìrus mononegaviral recombinante
ZA936629B (en) Potentiation of immunogenic response
WO2007047938A3 (en) Influenza viruses able to infect canids, uses thereof
PL360990A1 (en) Vaccines containing ribavirin and methods of use thereof
WO2003076591A3 (en) Compositions and methods for generating an immune response
WO2008048984A3 (en) Methods and compositions for preparing a universal influenza vaccine
WO2009051823A3 (en) Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof
NO983946L (no) Parapoxviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
ATE518012T1 (de) Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung
TW200502246A (en) Vaccine
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
ATE461283T1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
DE69533067D1 (de) Hepatis e-virus antigene und dessen verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties